Sub-retinal Transplantation of hESC Derived RPE(MA09-hRPE)Cells in Patients With Stargardt's Macular Dystrophy
Clinical trial NCT01345006 · COMPLETED
Trial details
- NCT number
- NCT01345006
- Sponsor
- Astellas Institute for Regenerative Medicine
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-16
- Primary completion
- 2015-08-10
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.